Evidence map›Paper›PMID 39990906›Full record

ArticleKidney international reports2025

Patients With Immunoglobulin A Nephropathy Show Abnormal Frequencies of B Cell Subsets, Unconventional T Cells, and High Levels of Galactose-Deficient IgA1-Coated Gut Bacteria.

Micaela Gentile, Nina Goerlich, I-Ju Lo, N Eric Olson, Mark McConnell, Johannes Pospiech, Tobias Bohnenpoll, Philipp Skroblin, Olivier Radresa, Uwe Andag and 11 more

Abstract read
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Gut Mucolytic Bacteria Is Associated with IgA Nephropathy.Journal of the American Society of Nephrology : JASN · 2026
    Article
  8. Article
  9. Unconventional T Cells in IgA Nephropathy.Kidney international reports · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Micaela GentileRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Nina GoerlichRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
I-Ju LoEvotec International GmbH, Göttingen, Germany.
N Eric OlsonChinook Therapeutics, Seattle, Washington, USA.
Mark McConnellChinook Therapeutics, Seattle, Washington, USA.
Johannes PospiechEvotec International GmbH, Göttingen, Germany.
Tobias BohnenpollEvotec International GmbH, Göttingen, Germany.
Philipp SkroblinEvotec International GmbH, Göttingen, Germany.
Olivier RadresaEvotec International GmbH, Göttingen, Germany.
Uwe AndagEvotec International GmbH, Göttingen, Germany.
Kirk N CampbellRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kristin MeliambroRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Luis Sanchez-RussoRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Alberto VerlatoRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Enrico FiaccadoriUO Nefrologia, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.
Seunghee Kim-SchulzeHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Maria LanauServicio de Nefrología, Unidad de Hemodiálisis, Hospital de Navarra, Pamplona, Spain.
M Loreto Fernandez-LorenteServicio de Nefrología, Unidad de Hemodiálisis, Hospital de Navarra, Pamplona, Spain.
Miguel FribourgRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Joaquin ManriqueServicio de Nefrología, Unidad de Hemodiálisis, Hospital de Navarra, Pamplona, Spain.
Paolo CravediRenal Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mucosal inflammation is involved in the pathophysiology of immunoglobulin-A nephropathy (IgAN); however, peripheral immune phenotype analyses of patients with IgAN often do not include unconventional T cells, the major subset in mucosal immunity. Methods: We measured serum total IgA, galactose-deficient IgA1 (gd-IgA1), secretory IgA (SIgA), B cell-activating factor (BAFF), and A proliferation-inducing ligand (APRIL) in 66 patients with IgAN and 30 healthy controls (HCs). We also quantified the total IgA and gd-IgA1 in stool supernatant along with the same coated on bacteria. In 35 patients and 14 controls, we performed extensive phenotyping using cytometry by Time-of-Flight (CyTOF) of circulating immune cells, including unconventional T cells (mucosal associated invariant T [MAIT] cells, γδ T, and natural killer [NK] T cells). The results were validated using RNAseq data from a larger cohort of 179 patients with IgAN, 140 patients with minimal change disease, and 91 HCs. Results: Patients with IgAN had higher circulating levels of total IgA, gd-IgA1, and APRIL, and higher IgA and gd-IgA1-coated gut bacteria than controls, whereas serum levels of SIgA and BAFF did not differ between groups. Patients with IgAN showed more class-switched memory (CSM) and double negative (DN) B cells than controls. MAIT cells and γδ T cells were significantly lower, and CD4 Conclusion: The data indicate that patients with IgAN have increased circulating CSM and DN B cells associated with abnormal T cell immunity, involving defects in unconventional T cell frequency. This may suggest putative alterations at mucosal sites because of cell migration leading to altered IgA production.

Indexed as

B cellIgA nephropathyimmune phenotypeinnate immunityT cell

Identifiers

PMID39990906
PMCPMC11843297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.